{"id":"W3087419444","doi":"10.1016/j.clml.2020.09.003","title":"Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Janssen Biotech; National Cancer Institute; Eisai Incorporated; National Institutes of Health; Galderma; Kyowa Hakko Kirin; Kyowa Kirin Pharmaceutical Development; Manitoba Beekeepers' Association; Portola Pharmaceuticals; Celgene; Takeda Pharmaceuticals U.S.A.; Novartis; Helsinn Therapeutics; Merck","keywords":"Medicine; Vorinostat; Monoclonal antibody; Monoclonal; Lymphoma; Oncology; Cancer research; Antibody; Internal medicine; Immunology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008626885,0.000603791,0.002309004,0.0001534117,0.0001133702,0.00002610519,0.0007976024,0.0004552272,0.00009457469],"category_scores_gemma":[0.006134448,0.0004105766,0.0007086876,0.001159872,0.001175553,0.0001165972,0.0004826604,0.0004155201,0.00005067623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006804621,"about_ca_system_score_gemma":0.003234449,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000403707,"about_ca_topic_score_gemma":0.00004067586,"domain_scores_codex":[0.9926627,0.001354652,0.002326576,0.001059556,0.001807819,0.0007886856],"domain_scores_gemma":[0.9931756,0.003420174,0.000916474,0.001178522,0.0006114435,0.0006977557],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05788359,0.001337541,0.881143,0.0007257125,0.0003066547,0.0001844583,0.0002412831,0.00008271177,0.0009511473,0.00003322727,0.0002044442,0.05690618],"study_design_scores_gemma":[0.05614721,0.008246353,0.9287552,0.000196108,0.0001374471,0.0000372121,0.00008609874,0.001388194,0.004431875,0.000009303641,0.0001895299,0.0003754226],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956051,0.0002079087,0.00001800359,0.0003916083,0.0002997811,0.001900901,0.0001656152,0.0000612088,0.001349943],"genre_scores_gemma":[0.9988399,0.00007996198,0.0001905096,0.0004386922,0.0001464547,0.000026092,0.0001167761,0.00009657175,0.00006508997],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05653076,"threshold_uncertainty_score":0.9998346,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03388055340965346,"score_gpt":0.3475230672563919,"score_spread":0.3136425138467384,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}